Katrien Asnong

Randomized, double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis1 1Gert Van Assche, Severine Vermeire, Geert D’Haens, and Paul Rutgeerts have been instrumental in the design of the study, trial management, data analysis, and writing the paper. Maja Noman had a major contribution in the clinical ambulatory follow-up of the patients in the trial. Martin Hiele followed cyclosporine levels and adjusted drug doses of patients in the trial and provided statistical advice. Katrien Asnong was the study coordinator and had a major share in data analysis. Joris Arts analyzed safety data and followed patients clinically during the trial. Andre D’Hoore and Freddy Penninckx performed the surgical interventions in patients failing the trial and substantially contributed in evaluating patients for colectomy.

Gert Van Assche, Geert D’Haens, Maja Noman et al. · Gastroenterology · 2003 · 446 citations

Medicine, Pharmacology, Pharmacotherapy +14

A pilot study on the use of the humanized anti-interleukin-2 receptor antibody daclizumab in active ulcerative colitis

G. Van Assche, Ignace Dalle, Maja Noman et al. · The American Journal of Gastroenterology · 2003 · 116 citations

Life Sciences, Immunology, Pharmacology +17

High-Dose Vitamin D Does Not Prevent Postoperative Recurrence of Crohn’s Disease in a Randomized Placebo-Controlled Trial

Jessica R. de Bruyn, Peter Bossuyt, Marc Ferrante et al. · Clinical Gastroenterology and Hepatology · 2020 · 37 citations · Full text

Medicine, Immunology, Nutrition +17

Incidence and Predictors of Success of Adalimumab Dose Escalation and De-escalation in Ulcerative Colitis: a Real-World Belgian Cohort Study

Saartje Van de Vondel, Filip Baert, C Reenaers et al. · Inflammatory Bowel Diseases · 2018 · 25 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +17